- Successful first half: Order intake1 up 27.5 percent, Group sales revenue up 17.9 percent, underlying EBITDA1 margin reaches 27.8 percent
- Stronger growth and higher profitability expected for the Bioprocess Solutions Division and the entire Group; outlook for the Lab Products & Services Division unchanged
PR Newswire
GĂ–TTINGEN, Germany, July 21, 2020